Axio Capital has acquired a 67.5% stake in Laboratoire Benewmedical, a French SME focused on innovative medical devices, as part of a capital reorganization aimed at driving growth in the regenerative surgery market.
Target Information
Laboratoire Benewmedical is a 35-year-old SME based in Melesse, Brittany, specialized in the distribution of innovative medical devices with high medico-economic value. The company is responsible for sourcing, negotiating distribution contracts, and ensuring the market availability, quality, and safety of the products for which it holds distribution rights. With a portfolio of approximately 800 references, the firm operates across three distinct product divisions: regenerative surgery, general surgery, and the extrahospital sector. Its devices are primarily aimed at both public and private hospitals, with a significant usage in operating rooms.
Industry Overview in France
The medical device industry in France is characterized by a robust infrastructure and a strong emphasis on innovation, placing a crucial role in healthcare delivery. France is one of the leading markets in Europe for medical technologies, benefitting from a well-established regulatory framework that facilitates the introduction of new products. The strong demand for advanced healthcare solutions has been increased by an aging population and rising health concerns, driving market growth.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The regenerative surgery sector, in particular, has witnessed significant advancements and investment, fueled by ongoing research and development initiatives. The dynamics of the indust
Similar Deals
Dentressangle → Naturacare et Dietopack
2023
ARCHIMED → FIM Medical
2023
Axio Capital → Laboratoire Benewmedical
2023
Turenne Santé → VLAD
2023
Axio Capital
invested in
Benewmedical
in 2023
in a Management Buyout / Buy-In (MBO) deal